Purchase Order 75N90024P00135
Award Date
1/9/24
Potential Completion Date
2/9/24
Potential Value
$20K
Federal Agency
NIH Clinical Center
Awardee
Omixon, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Beverly, MA 01915, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a firm fixed price purchase order to Omixon, Inc., a foreign-owned for-profit organization, for the supply of various biomedical products and services related to HLA genotyping. The contract, valued at $168,525.00, includes the delivery of Holotype HLA 24/11 kits, Promega GoTaq Long PCR Master Mix, and HLA Twin software to support the Clinical Center's research and development activities in HLA...
This $30,125.00 firm fixed price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Omixon, Inc., a foreign-owned for-profit corporation that specializes in providing biomedical products and services related to human leukocyte antigen (HLA) genotyping. The contract involves the supply of Omixon's Holotype HLA genotyping kits, which utilize next-generation sequencing (NGS) technology to support the NIH Clinical Center's ongoing research and clinical...
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center to Omixon, Inc., a molecular diagnostics company, to provide HLA genotyping products and services. The contract, valued at $201,985, was awarded through simplified acquisition procedures without full and open competition. Omixon is providing the NIH Clinical Center with Holotype next-generation sequencing (NGS) typing kits to support the Center's HLA...
The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a firm fixed-price purchase order to Omixon, Inc., a foreign-owned for-profit organization, to provide reagents in support of the NIH Clinical Center's research and development activities related to HLA testing and transplantation. The contract, valued at $101,220.00, did not utilize any set-aside programs. Omixon, as the prime contractor, has previously provided the NIH Clinical Center with...
This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Omixon, Inc., a foreign-owned for-profit corporation, for the supply of specialized biomedical products and services related to human leukocyte antigen (HLA) genotyping. The contract, valued at $30,125.00, does not have a set-aside designation, indicating that Omixon competed in the open market for this award. The contract appears to be part of the NIH Clinical Center's...
The U.S. Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $20,053.73 firm-fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer, for the supply of BIG DYE TERMINATOR SEQUENCING KITS AND ANCILLARY SUPPLIES, SEALS, PLATES, AND HIDIFORMAMIDE. This requirement was not set aside. Life Technologies Corporation serves as a prime contractor across various federal agencies, including...
The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a $12,185 purchase order to Life Technologies Corporation for items to support molecular diagnostic clinical testing. Life Technologies, a subsidiary of Thermo Electron Corporation Financial Services Division, will provide the contracted goods for use at its Grand Island, New York facility. The firm fixed price order runs from December 12, 2023 through January 12, 2024 and was awarded with no set...
This federal contract award is for the provision of the HUMANOMNIEXPRESSEXOME V1.2 DNA Analysis BeadChip (48 Samples) by Illumina, Inc. to the National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services. The $45,910.80 firm fixed price delivery order contract does not have a set-aside designation. The product being delivered supports genomic sequencing and analysis research. Illumina has a history of providing sequencing systems,...
The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a $11,900 purchase order to Hologic Sales and Service, LLC for products or services to be delivered between October 30, 2023 and January 5, 2024. As a division of Hologic, Inc., the prime contractor will provide unspecified items to the agency on a firm fixed price basis. No additional details were given regarding the original solicitation, major subcontractors, or whether the award contains any...
This is a $76,275.50 firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health (NIH) Clinical Center to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for HID Assurance Plus Coverage on a QuantStudio 6 Pro instrument and a service contract on a 3500XL Genetic Analyzer, both of which are used by the NIH Clinical Center's Department of Transfusion Medicine/Human Leukocyte Antigen (HLA) Lab...